| Financial Year |
March 31 2023 |
| Monetary Funds |
726,954,258.32 |
| Held-for-trading Financial Assets |
307,272,998.50 |
| Notes Receivable |
479,543.52 |
| Accounts Receivable |
440,859,728.22 |
| Advances to Suppliers |
32,752,317.27 |
| Other Receivables |
15,155,786.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
475,854,381.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,785,423.72 |
| Total Current Assets |
2,005,901,314.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
647,785,198.57 |
| Under-construction Projects |
5,173,590.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
208,722,578.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,476,674.03 |
| Deferred Income Tax Assets |
10,552,532.46 |
| Other Non-Current Assets |
2,159,204.59 |
| Sub-Total of Non-Current Assets |
895,727,176.63 |
| Total Assets |
2,901,628,491.08 |
| Short-Term Loans |
200,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
76,324,529.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
43,010,672.71 |
| Taxes Payable |
15,139,344.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
80,302,070.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,382,284.49 |
| Other Current Liabilities |
708,669.64 |
| Sub-Total of Current Liabilities |
494,815,027.67 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,227,960.60 |
| Deferred Income Tax Liabilities |
5,854,805.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
28,500,775.79 |
| Total Liabilities |
523,315,803.46 |
| Paid-In Capital(Or Share Stock) |
401,703,500.00 |
| Capital Surplus |
622,914,608.47 |
| Surplus Reserve |
125,996,059.74 |
| LESS:Treasury Stock |
24,293,185.00 |
| Undistributed Profits |
1,245,696,486.16 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,378,312,687.62 |
| Owner's Equity（Stockholder's Equity） |
2,378,312,687.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,901,628,491.08 |
